Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
Cancers|February 16, 2019
The Diverse Consequences of FOXC1 Deregulation in CancerL Niall Gilding, Tim C P SomervailleMolecular & Cellular Oncology|June 17, 2016
Tissue-inappropriate derepression of FOXC1 is frequent and functional in human acute myeloid leukemiaTim D D Somerville, Tim C P SomervailleThe American Journal of Emergency Medicine|June 26, 2021
Chronic myeloid leukemia presenting as compartment syndrome with acute loss of upper limb functionNatasha D'Souza, Tim C P Somervaille, David J MowattBritish Journal of Haematology|March 5, 2003
Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitorsTim C P Somervaille, David C Linch, Asim KhwajaExpert Opinion on Therapeutic Targets|September 11, 2012
LSD1 inhibition: a therapeutic strategy in cancer?James T Lynch, William J Harris, Tim C P SomervailleEjhaem|July 8, 2025
Bleeding Complications in JAK2-Variant Essential Thrombocythemia: A Revisit in 2025Gerard Gurumurthy, Samantha Gurumurthy, Tim C P Somervaille, et al.Hemasphere|November 15, 2019
AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor CellsStella Pearson, Rognvald Blance, Tim C P Somervaille, et al.Molecular & Cellular Oncology|September 26, 2018
LSD1 inhibitors disrupt the GFI1 transcription repressor complexAlba Maiques-Diaz, James T Lynch, Gary J Spencer, et al.Blood|April 17, 2010
Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6Michaela Liedtke, Paul M Ayton, Tim C P Somervaille, et al.Nature|September 23, 2008
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapyZhong Wang, Kevin S Smith, Mark Murphy, et al.Pageof 8